PolTREG S.A.
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.
PolTREG S.A. (PTG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.154x
Based on the latest financial reports, PolTREG S.A. (PTG) has a cash flow conversion efficiency ratio of -0.154x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-7.63 Million) by net assets (zł49.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PolTREG S.A. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how PolTREG S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PolTREG S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PolTREG S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tomei Consolidated Bhd
KLSE:7230
|
0.017x |
|
Shankara Building Products Limited
NSE:SHANKARA
|
-0.023x |
|
0DG8
LSE:0DG8
|
N/A |
|
HCT Co. Ltd
KQ:072990
|
0.186x |
|
ISE Chemicals Corporation
OTCGREY:ICHMF
|
N/A |
|
Trigg Minerals Limited
OTCQB:TMGLF
|
-0.947x |
|
INICS Corp.
KQ:452400
|
-0.010x |
|
Glaston Oyj Abp
HE:GLA1V
|
0.006x |
Annual Cash Flow Conversion Efficiency for PolTREG S.A. (2018–2024)
The table below shows the annual cash flow conversion efficiency of PolTREG S.A. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł69.23 Million | zł-16.00 Million | -0.231x | -52.30% |
| 2023-12-31 | zł87.52 Million | zł-13.28 Million | -0.152x | -78.29% |
| 2022-12-31 | zł101.04 Million | zł-8.60 Million | -0.085x | -128.55% |
| 2021-12-31 | zł103.01 Million | zł-3.84 Million | -0.037x | +82.85% |
| 2020-12-31 | zł12.83 Million | zł-2.79 Million | -0.217x | -100.11% |
| 2019-12-31 | zł-6.00K | zł-1.19 Million | 198.333x | +14627.96% |
| 2018-12-31 | zł764.00K | zł-1.04 Million | -1.365x | -- |